Kathleen Ludwig, MD
Pediatric Hematologist/Oncologist
Associate Professor at UT Southwestern Medical Center
- Languages Spoken:
- English Spanish
Biography
Kathleen Ludwig, M.D., is a Pediatric Oncologist at Children’s Health℠ and an Associate Professor of Pediatric Hematology-Oncology at UT Southwestern. Dr. Ludwig has a special interest in caring for patients with leukemia, lymphoma, relapsed leukemia and lymphadenopathy, as well as managing general pediatric oncology disorders. She also devotes part of her practice to treating patients with vascular anomalies.
Families play a vital role in the care of their child with cancer, and I work closely with them to provide the best, most informed care possible.
Dr. Ludwig earned her medical degree from Loyola Stritch School of Medicine. She completed her residency in general pediatrics and fellowship in pediatric hematology-o/oncology at UT Southwestern Medical Center.
In addition to treating patients, Dr. Ludwig conducts cancer research aiming to find new medicines and improve survival for patients whose leukemia comes back after treatment. She is an active member of the Children’s Oncology Group, a global consortium of researchers working to improve care and outcomes for children with cancer worldwide.
“Families play a vital role in the care of their child with cancer, and I work closely with them to provide the best, most informed care possible,” says Dr. Ludwig.
Education and Training
- Medical School
- Loyola University of Chicago, Stritch Sch of Med (2009)
- Residency
- UT Southwestern Medical Center (2012), Pediatrics
- Fellowship
- UT Southwestern - Childrens Medical Center (2015), Pediatric Hematology/Oncology
- Board Certification
- American Board of Pediatrics/Hematology-Oncology
Conditions
Treatments
Departments and Programs
-
Research Interests
- Leukemia
- Vascular Anomalies
-
Publications
- Response to Alpelisib in Clinically Distinct Pediatric Patients With PIK3CA-related Disorders. Kolitz E, Fernandes NJ, Agim NG, Ludwigl K, J Pediatr Hematol Oncol 2022 Feb
- Recent progress in the treatment of cancer in children. Butler E, Ludwig K, Pacenta HL, Klesse LJ, Watt TC, Laetsch TW, CA Cancer J Clin 2021 Apr
- Giant Congenital Melanocytic Nevus Treated With Trametinib. Mir A, Agim NG, Kane AA, Josephs SC, Park JY, Ludwig K Pediatrics 2019 Feb
- Small molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer. Ludwig KF, Du W, Sorrelle N, Wnuk-Lipinska K, Topalovski M, Toombs JE, Cruz VH, Yabuuchi S, Rajeshkumar NV, Maitra A, Lorens JB, Brekken RA Cancer Res. 2017 Nov
- A New Case and Review of Chylothorax in Generalized Lymphatic Anomaly and Gorham-Stout Disease. Ludwig KF, Slone T, Cederberg KB, Silva AT, Dellinger M Lymphology 2016 Jun 49 2 73-84
- Warfarin blocks Gas6-mediated Axl activation required for pancreatic cancer epithelial plasticity and metastasis. Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, Toombs JE, Wang M, Dineen SP, Micklem D, Dellinger MT, Lorens JB, Brekken RA Cancer Res. 2015 Jul
-
Professional Activities
- American Society of Clinical Oncology (2013)
- American Society of Hematology (2013)
- American Society of Pediatric Hematology/Oncology (2013)
- Children's Medical Center Oncology Group (2013)
-
Awards and Honors
- Best Pediatric Subspecialist - D-Magazine (2021-2023)
- Best Poster award - UT Southwestern Pediatric Fellow's Research Symposium (2015)
- Best Basic Science Award - Annual Surgical Research Forum, UT Southwestern (2014)
- Above-and-Beyond Recognition for Excellence - UT Southwestern Pediatric Residency Program (2010)
